American Well Corporation AMWL
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Ask Irving AI About AMWL
Get to know the stock you’re researching through a simple conversation. Ask Irving about its Weiss rating, financial health, dividends, and potential risks — right from the stock page.
Get answers about this stock. Instantly.
Ask about the company’s financial health and its Weiss Safety, Reward, and Risk Ratings, with answers grounded in Weiss Ratings data.
Understand the numbers behind the rating.
Explore profits, cash flow, valuation, and dividends. Ask follow-up questions without leaving the stock page.
Put the stock’s strengths and risks in context.
Look beyond a single number. Explore rating changes and company trends to better understand the stock’s outlook.
Company Overview
American Well Corporation, commonly known as Amwell, is a U.S.-based digital healthcare and telehealth technology company that provides virtual care infrastructure, software platforms, and clinical program support for healthcare providers, health plans, employers, and government organizations. The company operates within the digital health, healthcare technology, and telemedicine industries, with a primary focus on enabling remote clinical interactions and integrated virtual healthcare delivery. Its core revenue drivers include subscription-based platform services, software licensing, professional services, and technology-enabled healthcare solutions delivered through its enterprise virtual care platform.
Amwell’s primary platform, Converge, is designed to support hybrid care delivery by integrating virtual and in-person healthcare workflows across multiple care settings. The company serves large health systems, insurers, and government entities, particularly in the United States healthcare market. Amwell was founded in 2006 by physicians Ido Schoenberg and Roy Schoenberg and evolved from an early telemedicine service provider into an enterprise-focused digital care infrastructure company. Its strategic positioning centers on interoperability with electronic health record systems, scalable cloud-based virtual care technology, and long-term enterprise relationships with major healthcare organizations.
Business Operations
Amwell generates revenue primarily through subscription arrangements, implementation services, platform licensing, and support services tied to its virtual care ecosystem. The company’s operations are organized around enterprise virtual healthcare technology and clinical enablement solutions. Its platform supports telehealth visits, remote patient monitoring, automated care programs, digital triage, behavioral health, specialty consultations, and hospital-based virtual care workflows. The company also provides tools that integrate with healthcare IT systems, including electronic medical records and payer systems.
The company operates primarily in the United States but has historically maintained international relationships and technology collaborations. Amwell controls proprietary virtual care software infrastructure and cloud-based healthcare workflow technology through its Converge platform architecture. Major strategic relationships have included collaborations with large health insurers and health systems, including longstanding partnerships with organizations such as Cleveland Clinic and CVS Health’s healthcare operations. Amwell has also worked with government and public-sector healthcare programs to expand digital care access.
Strategic Position & Investments
Amwell’s strategic direction has focused on expanding enterprise adoption of its unified virtual care platform and transitioning customers toward the Converge architecture. The company has invested heavily in platform modernization, interoperability capabilities, artificial intelligence-enabled workflow tools, and scalable cloud infrastructure intended to support long-term hybrid healthcare delivery models. Its growth initiatives have included expanding behavioral health offerings, hospital-at-home support capabilities, and digital care automation tools.
The company has completed acquisitions and strategic investments intended to strengthen its technology portfolio and clinical engagement capabilities. Notable acquisitions have included SilverCloud Health, a digital mental health platform, and Conversa Health, a patient engagement and automated care management company. These acquisitions broadened Amwell’s capabilities in behavioral health, automated outreach, and longitudinal patient management. The company has also pursued collaborations involving connected care technologies and digital health integrations to strengthen its position within enterprise healthcare ecosystems.
Geographic Footprint
Amwell is headquartered in Boston, Massachusetts, and its primary operational focus is the United States healthcare market. The company serves healthcare systems, insurers, employers, and government-related healthcare organizations across multiple U.S. regions. Its platform infrastructure is designed to support large-scale healthcare networks and nationwide telehealth deployments.
Although the majority of revenue and operational activity is concentrated in North America, Amwell has maintained international exposure through technology partnerships, acquired businesses, and collaborative healthcare initiatives. The acquisition of SilverCloud Health, which originated in Ireland, expanded the company’s international technology presence and digital behavioral health reach. Public filings and company disclosures indicate that Amwell’s commercial emphasis remains predominantly U.S.-centric despite selected international relationships and technology assets.
Leadership & Governance
Amwell was founded by physicians Ido Schoenberg and Roy Schoenberg, both of whom played significant roles in shaping the company’s focus on scalable digital healthcare delivery. Leadership strategy has emphasized integrated virtual care, interoperability with existing healthcare infrastructure, and enterprise healthcare transformation through hybrid care models. Public statements and corporate filings consistently position the company as focused on long-term healthcare digitization rather than short-term direct-to-consumer telehealth expansion.
Key executives include:
- Ido Schoenberg – Chairman and Chief Executive Officer
- Roy Schoenberg – President and Co-Chief Executive Officer
- Robert Shepardson – Chief Financial Officer
- Phyllis Gotlib – Chief Commercial Officer
- Peter Antall – Chief Medical Officer
Leadership and governance information has been consistently reflected in SEC filings, investor presentations, and company disclosures. Some executive roles and reporting structures have changed periodically following operational restructuring initiatives; where timing differences appeared across public materials, the most recent publicly available filings were prioritized.